These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 27686121)
21. Design, Synthesis, and Properties of a Potent Inhibitor of Pseudomonas aeruginosa Deacetylase LpxC. Piizzi G; Parker DT; Peng Y; Dobler M; Patnaik A; Wattanasin S; Liu E; Lenoir F; Nunez J; Kerrigan J; McKenney D; Osborne C; Yu D; Lanieri L; Bojkovic J; Dzink-Fox J; Lilly MD; Sprague ER; Lu Y; Wang H; Ranjitkar S; Xie L; Wang B; Glick M; Hamann LG; Tommasi R; Yang X; Dean CR J Med Chem; 2017 Jun; 60(12):5002-5014. PubMed ID: 28549219 [TBL] [Abstract][Full Text] [Related]
22. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009]. Hamouche E; Sarkis DK Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212 [TBL] [Abstract][Full Text] [Related]
23. Structure-activity relationship study using peptide arrays to optimize Api137 for an increased antimicrobial activity against Pseudomonas aeruginosa. Bluhm ME; Knappe D; Hoffmann R Eur J Med Chem; 2015 Oct; 103():574-82. PubMed ID: 26408816 [TBL] [Abstract][Full Text] [Related]
24. Mechanistic analysis of a synthetic inhibitor of the Pseudomonas aeruginosa LasI quorum-sensing signal synthase. Lidor O; Al-Quntar A; Pesci EC; Steinberg D Sci Rep; 2015 Nov; 5():16569. PubMed ID: 26593271 [TBL] [Abstract][Full Text] [Related]
25. Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa. Siriyong T; Srimanote P; Chusri S; Yingyongnarongkul BE; Suaisom C; Tipmanee V; Voravuthikunchai SP BMC Complement Altern Med; 2017 Aug; 17(1):405. PubMed ID: 28806947 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and pharmacological evaluation of pyrazolo[4,3-c]cinnoline derivatives as potential anti-inflammatory and antibacterial agents. Tonk RK; Bawa S; Chawla G; Deora GS; Kumar S; Rathore V; Mulakayala N; Rajaram A; Kalle AM; Afzal O Eur J Med Chem; 2012 Nov; 57():176-84. PubMed ID: 23059546 [TBL] [Abstract][Full Text] [Related]
27. Molecular Docking and Molecular Dynamics Studies to Identify Potential OXA-10 Extended Spectrum β-Lactamase Non-hydrolysing Inhibitors for Pseudomonas aeruginosa. Malathi K; Ramaiah S Cell Biochem Biophys; 2016 Jun; 74(2):141-55. PubMed ID: 27234361 [TBL] [Abstract][Full Text] [Related]
28. Identification and validation of a novel anti-virulent that binds to pyoverdine and inhibits its function. Wang X; Kleerekoper Q; Revtovich AV; Kang D; Kirienko NV Virulence; 2020 Dec; 11(1):1293-1309. PubMed ID: 32962519 [No Abstract] [Full Text] [Related]
29. Essential oils from Moroccan plants as potential chemosensitisers restoring antibiotic activity in resistant Gram-negative bacteria. Fadli M; Chevalier J; Saad A; Mezrioui NE; Hassani L; Pages JM Int J Antimicrob Agents; 2011 Oct; 38(4):325-30. PubMed ID: 21752605 [TBL] [Abstract][Full Text] [Related]
30. Optimization and Mechanistic Characterization of Pyridopyrimidine Inhibitors of Bacterial Biotin Carboxylase. Andrews LD; Kane TR; Dozzo P; Haglund CM; Hilderbrandt DJ; Linsell MS; Machajewski T; McEnroe G; Serio AW; Wlasichuk KB; Neau DB; Pakhomova S; Waldrop GL; Sharp M; Pogliano J; Cirz RT; Cohen F J Med Chem; 2019 Aug; 62(16):7489-7505. PubMed ID: 31306011 [TBL] [Abstract][Full Text] [Related]
31. In vitro activity of S-(3,4-dichlorobenzyl)isothiourea hydrochloride and novel structurally related compounds against multidrug-resistant bacteria, including Pseudomonas aeruginosa and Burkholderia cepacia complex. Nicholson A; Perry JD; James AL; Stanforth SP; Carnell S; Wilkinson K; Anjam Khan CM; De Soyza A; Gould FK Int J Antimicrob Agents; 2012 Jan; 39(1):27-32. PubMed ID: 21993484 [TBL] [Abstract][Full Text] [Related]
32. Synthesis of 3-(1,3,4-thiadiazol-2-yl)pyrazolo[1,5-a] pyrimidine derivatives as potential antimicrobial agents. Auzzi G; Costanzo A; Bruni F; Clauser M; Guerrini G; Selleri S; Pecori Vettori L Farmaco; 1990 Nov; 45(11):1193-205. PubMed ID: 2128451 [TBL] [Abstract][Full Text] [Related]
36. Application of the multifactor dimensionality reduction method in evaluation of the roles of multiple genes/enzymes in multidrug-resistant acquisition in Pseudomonas aeruginosa strains. Yao Z; Peng Y; Bi J; Xie C; Chen X; Li Y; Ye X; Zhou J Epidemiol Infect; 2016 Mar; 144(4):856-63. PubMed ID: 26234343 [TBL] [Abstract][Full Text] [Related]
37. Investigation of Pseudomonas aeruginosa quorum-sensing signaling system for identifying multiple inhibitors using molecular docking and structural analysis methodology. Soheili V; Bazzaz BS; Abdollahpour N; Hadizadeh F Microb Pathog; 2015 Dec; 89():73-8. PubMed ID: 26358567 [TBL] [Abstract][Full Text] [Related]
38. Antibacterial activity of flavonoid isolated from Trianthema decandra against Pseudomonas aeruginosa and molecular docking study of FabZ. Geethalakshmi R; Sundaramurthi JC; Sarada DVL Microb Pathog; 2018 Aug; 121():87-92. PubMed ID: 29763727 [TBL] [Abstract][Full Text] [Related]
39. Potent LpxC Inhibitors with Krause KM; Haglund CM; Hebner C; Serio AW; Lee G; Nieto V; Cohen F; Kane TR; Machajewski TD; Hildebrandt D; Pillar C; Thwaites M; Hall D; Miesel L; Hackel M; Burek A; Andrews LD; Armstrong E; Swem L; Jubb A; Cirz RT Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451507 [TBL] [Abstract][Full Text] [Related]
40. Targeting the Bacterial Epitranscriptome for Antibiotic Development: Discovery of Novel tRNA-(N Zhong W; Koay A; Ngo A; Li Y; Nah Q; Wong YH; Chionh YH; Ng HQ; Koh-Stenta X; Poulsen A; Foo K; McBee M; Choong ML; El Sahili A; Kang C; Matter A; Lescar J; Hill J; Dedon P ACS Infect Dis; 2019 Mar; 5(3):326-335. PubMed ID: 30682246 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]